Will AI Finally Defeat Chronic Diseases Like ...

Even though Imagine This... has come to an end, you can still join BCG as we explore AI on our sister podcast, The So What from BCG. https://lnk.to/so-what-general-show10Here we share an excerpt from a recent episode, "How BCG Is Rewriting Its Talent Playbook in the Age of AI,"wh ...  Show more

We just closed the books on Imagine This season two and the series. But we aren’t done quite yet! In this bonus episode, we're going to peel back the curtain and speak with Bill Moore and GENE about working with agents, what we've learned, and where all of this is heading.Learn M ...  Show more

Human beings are living longer than ever. Thanks to advances like vaccines, antibiotics, pasteurized milk and clean water, we’ve added more than 30 years to the average lifespan over the last 120 years. That’s more than was added in the previous 10,000 years combined. More recent ...  Show more

Today's guest is Dan Elton, Staff Scientist at the National Human Genome Research Institute (NHGRI) at the National Institutes of Health (NIH). Dan returns to explore the transformative role of AI in healthcare. In his new role, Dan shares how his work at NIH focuses on integr ...

Bringing new drugs to market is a costly, time-consuming endeavor. On top of that, most medicines fail at some point in the research and development phase. Sarah Guo is joined by Sajith Wickramasekara, co-founder and CEO of Benchling, a company that has not only become the centra ...  Show more

Today's guest is Nishtha Jain, Head of Innovation and Digital Technology at Takeda Pharmaceuticals. Nistha returns to the program to discuss the transformative impact of AI across the pharmaceutical value chain. She and Emerj Editorial Director Matthew DeMello explore how AI i ...